SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 21 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,365,000 | +61.1% | 4,500,000 | +28.6% | 0.12% | +29.2% |
| Q1 2020 | $8,295,000 | +1628.1% | 3,500,000 | +1066.7% | 0.09% | +2125.0% |
| Q4 2019 | $480,000 | -10.6% | 300,000 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $537,000 | +23.2% | 300,000 | -13.0% | 0.01% | +25.0% |
| Q2 2019 | $436,000 | -32.0% | 344,681 | -1.5% | 0.00% | -33.3% |
| Q1 2019 | $641,000 | +59.1% | 350,000 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $403,000 | -48.1% | 350,000 | 0.0% | 0.00% | -42.9% |
| Q3 2018 | $777,000 | -9.4% | 350,000 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $858,000 | -81.0% | 350,000 | 0.0% | 0.01% | -89.1% |
| Q1 2018 | $4,515,000 | +307.5% | 350,000 | +250.0% | 0.05% | +318.2% |
| Q4 2017 | $1,108,000 | -11.5% | 100,000 | 0.0% | 0.01% | -21.4% |
| Q3 2017 | $1,252,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS (UK) LLP | 2,667,350 | $7,922,000 | 0.33% |
| Polar Capital LLP | 4,500,000 | $13,365,000 | 0.12% |
| Inscription Capital, LLC | 17,000 | $50,000 | 0.03% |
| BBR PARTNERS, LLC | 50,000 | $149,000 | 0.02% |
| Checchi Capital Advisers, LLC | 20,000 | $59,000 | 0.01% |
| Cornerstone Investment Partners, LLC | 34,825 | $103,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 49,257 | $146,000 | 0.00% |
| Renaissance Technologies | 361,112 | $1,073,000 | 0.00% |
| HSBC HOLDINGS PLC | 150,975 | $448,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 11,000 | $35,000 | 0.00% |